Viewing Study NCT06678659

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:24 PM
Ignite Modification Date: 2026-01-31 @ 7:51 AM
Study NCT ID: NCT06678659
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2024-10-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
Sponsor: Recursion Pharmaceuticals Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Unresectable View
None Locally Advanced View
None Metastatic Cancers View
None Relapsed/Refractory Lymphomas View
Keywords:

Keywords

Keyword Brief Keyword Text View
None RBM39 View
None Cancer View
None Refractory Lymphomas View
None Metastatic Cancers View